Introduction: The use of Swedish oral moist snuff, known as snus, has for a long time been limited to the Scandinavian countries. With declining cigarette sales in the western world, tobacco companies have looked to the development of alternative tobacco products. In 2006 snus products were launched in the US. Even though several studies have demonstrated negative health effects, snus is often depicted as harmless. The aim of the present study was to investigate acute vascular effects of snus as measured by arterial stiffness as well as blood pressure and heart rate. Methods: Two separate randomized double-blind crossover studies with the same study design were pooled for analysis. Twenty-nine healthy snus-users (17 females, 12 males) were ...
Previous investigations of snus use (oral moist snuff, a Swedish form of smokeless tobacco) and card...
Snus is a common tobacco product in Sweden, but the cardiovascular risk profile for snus users is le...
Tobacco smoking is an important risk factor for peripheral artery disease (PAD), but it remains unkn...
Introduction: The use of Swedish oral moist snuff, known as snus, has for a long time been limited t...
The use of Swedish oral moist snuff, known as snus, has for a long time been limited to the Scandina...
Background: Snus usage is commonly touted as a safer alternative to cigarette smoking. However, rece...
Snus is a smokeless tobacco product made of a moist powder of ground tobacco. It is used mainly in t...
Use of snus is most prevalent in Nordic countries, and especially in Sweden, where 18% of men and 3%...
The use of snus (also referred to as Scandinavian or Swedish moist smokeless tobacco), which is comm...
Introduction: Snus is a very popular tobacco-alternative in Sweden with 18% of males and 4% of femal...
Background: Cigarette smoking is a well-known risk factor for cardiovascular disease (CVD), but whet...
INTRODUCTION: Studies of the health effects of moist oral tobacco, snus, have produced inconsistent ...
Previous investigations of snus use (oral moist snuff, a Swedish form of smokeless tobacco) and card...
Snus is a common tobacco product in Sweden, but the cardiovascular risk profile for snus users is le...
Tobacco smoking is an important risk factor for peripheral artery disease (PAD), but it remains unkn...
Introduction: The use of Swedish oral moist snuff, known as snus, has for a long time been limited t...
The use of Swedish oral moist snuff, known as snus, has for a long time been limited to the Scandina...
Background: Snus usage is commonly touted as a safer alternative to cigarette smoking. However, rece...
Snus is a smokeless tobacco product made of a moist powder of ground tobacco. It is used mainly in t...
Use of snus is most prevalent in Nordic countries, and especially in Sweden, where 18% of men and 3%...
The use of snus (also referred to as Scandinavian or Swedish moist smokeless tobacco), which is comm...
Introduction: Snus is a very popular tobacco-alternative in Sweden with 18% of males and 4% of femal...
Background: Cigarette smoking is a well-known risk factor for cardiovascular disease (CVD), but whet...
INTRODUCTION: Studies of the health effects of moist oral tobacco, snus, have produced inconsistent ...
Previous investigations of snus use (oral moist snuff, a Swedish form of smokeless tobacco) and card...
Snus is a common tobacco product in Sweden, but the cardiovascular risk profile for snus users is le...
Tobacco smoking is an important risk factor for peripheral artery disease (PAD), but it remains unkn...